Fernando Terry

Dr. Fernando Terry

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TMTania Maldonado-Valer
Tania Maldonado-Valer
LPLuis F Pareja-Mujica
Luis F Pareja-Mujica
RCRodrigo Corcuera-Ciudad
Rodrigo Corcuera-Ciudad
FTFernando Terry
Fernando Terry
MCMylenka Jennifer Chevarría-Arriaga
Mylenka Jennifer Chevarría-Arriaga
MYMarlon Yovera-Aldana
Marlon Yovera-Aldana
Aims: To determine the overall prevalence of diabetic foot at risk according to the International Working Group on the Diabetic Foot stratification. Materials and methods: We searched PubMed/Medline, Scopus, Web of Science, and Embase. We included cross-sectional studies or cohorts from 1999 to March 2022. We performed a meta-analysis of proportions using a random-effects model. We assessed heterogeneity through subgroup analysis by continent and other characteristics. Results: We included 36 studies with a total population of 11,850 people from 23 countries. The estimated overall prevalence of diabetic foot at risk was 53.2% (95% CI: 45.1–61.3), I2 = 98.7%, p < 0.001. In the analysis by subgroups, South and Central America had the highest prevalence and Africa the lowest. The factors explaining the heterogeneity were the presence of chronic kidney disease, diagnostic method for peripheral arterial disease, and quality. The estimates presented very low certainty of evidence. Conclusions: The overall prevalence of diabetic foot at risk is high. The high heterogeneity between continents can be explained by methodological aspects and the type of population. However, using the same classification is necessary for standardization of the way of measuring the components, as well as better designed general population-based studies.

18 September 2024 in Neurosurgical Review
Verified
Journal Article
Closed access
PDF file
FTFernando Terry
Fernando Terry
ELEvan Luther
Evan Luther
ARAaron Rodriguez-Calienes
Aaron Rodriguez-Calienes
JLJaime Lopez-Calle
Jaime Lopez-Calle
BDBruno Diaz-Llanes
Bruno Diaz-Llanes
JSJoel Sequeiros
Joel Sequeiros

1 August 2023 in Neurosurgical Focus
Verified
Journal Article
Open access
PDF file
FTFernando Terry
Fernando Terry
MMMartin A. Merenzon
Martin A. Merenzon
LDLekhaj Daggubati
Lekhaj Daggubati
KZKyle Zullo
Kyle Zullo
ALAdam S. Levy
Adam S. Levy
MIMichael E. Ivan
Michael E. Ivan
OBJECTIVE: Brain metastases (BMs) are the most common intracranial tumors. In several cases, they present as large masses, which are related to a worse prognosis and more complex therapeutic alternatives. Staged radiosurgery is reported to achieve local control with minimal radiation-related adverse events in BMs. However, no methodological consensus has been achieved in its use for large brain metastases (LBMs; > 2 cm). Therefore, the authors aimed to determine the effectiveness and safety of 2-stage Gamma Knife radiosurgery (GKRS) for LBMs, in order to optimize patients’ postoperative course. METHODS: A systematic review of available literature was run in PubMed/MEDLINE, Scopus, Web of Science, Cochrane (OvidSP), and Google Scholar for works published up to December 14, 2022. Nonrandomized clinical trials, case series, and cohort studies were included. The risk of bias was assessed using the Risk of Bias in Nonrandomized Studies–of Interventions (ROBINS-I) and Joanna Briggs Institute tools. Pooled mean difference and rates estimates were calculated by a random-effects model meta-analysis. The degree of heterogeneity was expressed using the I 2 statistic. A subgroup analysis was performed. Ultimately, the certainty of evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) assessment. RESULTS: Fourteen studies met the eligibility criteria (cohorts, case series, and nonrandomized clinical trials), including 958 patients. A total pooled mean volume reduction of 6.27 cm 3 (95% CI 5.67–6.88 cm 3 ) and 54.36% (95% CI 39.92%–68.79%) after 2-stage GKRS was reported. Pooled rates of complete response (44.63%; 95% CI 26.50%–64.31%), neurological mortality (16.19%; 95% CI 7.68%–30.98%), and all-cause mortality (47.92%; 95% CI 28.04%–68.49%) were calculated. Overall certainty of evidence ranged from very low to moderate. CONCLUSIONS: Two-stage GKRS is an effective and safe approach for the treatment of LBMs. Nevertheless, the lack of available literature and the weak methodological approaches used determine a low to very low certainty of evidence and cannot provide robust evidence to recommend this intervention. Therefore, it is necessary to conduct higher-quality primary studies.

Verified
Journal Article
Open access
PDF file
FTFernando Terry
Fernando Terry
AEAlejandro Enríquez-Marulanda
Alejandro Enríquez-Marulanda
NPNathaly Olga Chinchihualpa Paredes
Nathaly Olga Chinchihualpa Paredes
MCMeiling Carbajal-Galarza
Meiling Carbajal-Galarza
CCClaudia Vidal Cuellar
Claudia Vidal Cuellar
JLJaime Lopez-Calle
Jaime Lopez-Calle
Background/Objectives: Aneurysmal subarachnoid hemorrhage (aSAH) is a medical emergency with a high mortality rate requiring urgent treatment. This study aimed to identify clinical predictors of inpatient mortality and poor postoperative course after aSAH surgical clipping. Methods: We performed a retrospective review of medical records for 210 patients with aSAH treated via surgical clipping at our institution between 2010 and 2019. Baseline demographic data and clinical characteristics related to aSAH were collected. To identify factors associated with inpatient mortality and a poor postoperative course after aSAH microsurgical clipping, we conducted a univariate and bivariate analysis, as well as a multivariate analysis via the Poisson regression model. Results: The overall cumulative mortality over the 10-year study period was 11.43%. A severe WFNS scale score (aRR: 2.86; 95% CI: 1.28–6.39; p = 0.011) and having 1 (aRR: 5.76; 95% CI: 2.02–16.39, p = 0.001) or ≥2 (aRR: 18.86; 95% CI: 5.16–68.90, p < 0.001) postoperative neurosurgical complications were associated with an increased risk of inpatient mortality. A moderate (aRR: 3.71; 95% CI: 1.45–9.50; p = 0.006) or severe (aRR: 4.18; 95% CI: 1.12–15.60; p = 0.034) Glasgow scale score on admission, and presenting 1 (aRR: 2.31; 95% CI: 1.27–4.19; p = 0.006) or ≥2 postoperative clinical complications (aRR: 3.34; 95% CI: 1.83–6.10; p < 0.001) were associated with an increased risk of a poor postoperative course. Conclusions: While promising and widely supported by the published literature, these findings require further validation in a larger prospective and multi-centered study to adequately propose health policies on neurointensive care for the Peruvian population. Ultimately, developing socioeconomic setting-focused intervention algorithms and clinical practice guidelines could enhance the survival and postoperative course of patients presenting with aSAH.

15 October 2025 in North American Spine Society Journal (NASSJ)
Verified
Journal Article
Open access
MAMichael Avery
Michael Avery
FTFernando Terry
Fernando Terry
APAndrew Y. Powers
Andrew Y. Powers
FYForough Yazdanian
Forough Yazdanian
CLChloe Lee
Chloe Lee
ZMZiev B. Moses
Ziev B. Moses
Elective lumbar decompression, commonly performed via laminectomy or microdiscectomy, is a well-tolerated surgical procedure. Patients requiring discharge to inpatient rehabilitation facilities are infrequent but generate increased healthcare costs and can be burdensome to patients and families. This study aims to develop an accurate predictive model for rehabilitation discharge following elective lumbar decompression, as well as to identify associated factors. This was a retrospective, single-center, cohort study. Current Procedural Terminology codes for laminectomy and microdiscectomy were used to identify patients from October 2012 to November 2024. Charts were reviewed to obtain additional demographic and clinical characteristics on which an initial univariate analysis was performed. Primary outcomes for this study included measurements of accuracy for predicting rehab discharge. Secondary outcomes included associations of variables with rehab discharge. Those with confounding diagnosis or admitted from a rehabilitation facility were excluded. Machine learning models were trained and evaluated on the data using cross-validation and classification metrics were utilized for model comparison. A total of 486 patients were considered for the analysis. After performing a Benjamini-Hochberg correction, the univariate analysis identified multiple statistically significant variables associated with rehabilitation discharge some of which include age, preoperative leg pain, lower extremity weakness, need for a walking assistive device, and frailty. Of the 5 machine learning models tested, the logistic regression model demonstrated superior performance, with the highest area under curve (0.81), Youden’s J statistic (0.55) and balanced accuracy (0.78). The logistic regression model demonstrated that age and the use of an ambulatory assistive device are consistently predictive of rehabilitation discharge (p<.001). When considered alongside frailty, lack of support, and other variables, age and the necessity for a walking assistive device can serve as a reliable predictors of rehabilitation discharge, thereby improving patient workflow, minimizing uncertainty and reducing healthcare costs.

11 March 2025 in Cancers
Verified
Journal Article
Open access
PDF file
FTFernando Terry
Fernando Terry
EOEduardo Orrego-Gonzalez
Eduardo Orrego-Gonzalez
AEAlejandro Enríquez-Marulanda
Alejandro Enríquez-Marulanda
NPNiels Pacheco
Niels Pacheco
MMMartin Merenzon
Martin Merenzon
RVRafael A. Vega
Rafael A. Vega
Background/Objectives: Breast cancer is the most common malignancy in women and the second leading cause of cancer-related deaths globally. It is also the second most frequent source of brain metastases (BMs), contributing to 5–20% of cases. Despite this, routine brain imaging for screening is not recommended and is only conducted when clinical symptoms or physical findings suggest metastasis. This study aims to identify clinical predictors associated with overall survival (OS) and the timing of BM development in breast cancer patients. Methods: We performed a retrospective review of medical records for 113 patients diagnosed with BMs secondary to breast cancer at our institution between 2000 and 2020. Baseline demographic data and clinical characteristics related to BMs were collected. To identify factors associated with OS and time to BM development after breast cancer diagnosis, we conducted univariate analysis using Kaplan–Meier curves, bivariate analysis with the log-rank test, and multivariate analysis via the Cox Proportional Hazard model. Results: An early diagnosis of BMs was identified as a significant predictor of prolonged OS (aHR = 0.22; 95% CI: 0.049–0.98, p = 0.05). Post-menopausal status at breast cancer diagnosis (aHR = 1.69; 95% CI: 1.13–2.53, p = 0.01), Asian ethnicity (aHR = 2.30; 95% CI: 1.03–5.16, p = 0.04), and the ER+/HER2+ subtype (aHR = 2.06; 95% CI: 1.14–3.71, p = 0.02) were significantly associated with a shorter time to BM diagnosis. A subgroup analysis of patients with ER+ breast tumors revealed that Hispanic or Arabic ethnicity (aHR = 3.63; 95% CI: 1.34–9.81, p = 0.01) and stage IV diagnosis (aHR = 2.09; 95% CI: 1.16–3.76, p = 0.01) were significantly associated with shorter intervals to BM diagnosis. Conclusions: Breast cancer remains a significant global health burden for women, yet clear guidelines for routine BMs screening are still lacking. Early detection of BMs has been shown to notably improve long-term survival outcomes. Additionally, post-menopausal status, Hispanic or Arabic ethnicity, and the HER2+ tumor subtype are associated with shorter time to BM development, highlighting these factors as potential indicators for central nervous system screening.